Intranasal Steroid Dosing for a 14-Year-Old
For a 14-year-old with allergic rhinitis, use 2 sprays per nostril once daily of any FDA-approved intranasal corticosteroid (INCS), as this age falls into the ≥12 years dosing category where all agents are dosed identically. 1
Specific Dosing by Agent
Based on FDA-approved guidelines for adolescents aged 12 years and older 1:
- Triamcinolone acetonide (Nasacort): 2 sprays per nostril once or twice daily (55 µg per spray)
- Mometasone furoate (Nasonex): 2 sprays per nostril once daily (50 µg per spray)
- Fluticasone propionate (Flonase): 2 sprays per nostril once daily (50 µg per spray)
- Fluticasone furoate (Veramyst): 2 sprays per nostril once daily (27.5 µg per spray)
- Ciclesonide (Omnaris): 2 sprays per nostril once daily (50 µg per spray)
- Ciclesonide (Zetonna): 1 spray per nostril once daily (37 µg per spray)
Clinical Context
Intranasal corticosteroids are the most effective medication class for controlling allergic rhinitis symptoms in adolescents, superior to oral antihistamines and montelukast for nasal symptom reduction. 2 They effectively address all four cardinal nasal symptoms: congestion, rhinorrhea, sneezing, and nasal itching, while also providing benefit for ocular symptoms. 2
When to Consider Combination Therapy
For moderate to severe seasonal allergic rhinitis, you may add an intranasal antihistamine (azelastine 548 µg) to the INCS regimen. 2 Studies demonstrate that fluticasone propionate 200 µg plus azelastine 548 µg as a combination spray produces clinically meaningful additional symptom reduction compared to INCS alone (symptom score reductions of -5.31 to -5.7 for combination vs -3.84 to -5.1 for INCS alone on a 24-point scale). 2
Safety Considerations for Adolescents
Intranasal corticosteroids are safe in the pediatric and adolescent population when used at FDA-approved doses. 3, 4 Key safety points:
- Growth effects: Short-term growth velocity reduction may occur with some agents, but long-term stadiometry studies show no significant impact on final adult height 4, 5
- Local side effects: Epistaxis (5-10%), nasal irritation, headache, and pharyngitis are most common but rarely severe 1, 6
- Systemic effects: HPA axis suppression and ocular changes are uncommon with FDA-approved nasal spray formulations 3, 4
Critical Pitfall to Avoid
Never use intranasal corticosteroid drops (non-FDA-approved formulations) in children or adolescents, as these carry increased risk of iatrogenic Cushing's syndrome due to higher systemic absorption. 4 Stick to FDA-approved nasal spray formulations only.
Practical Administration
- Start at the standard dose (2 sprays per nostril daily) rather than titrating up
- Administer in the morning for once-daily dosing
- Maximal efficacy typically achieved within 1-2 weeks of regular use
- Continue daily use throughout allergy season for optimal symptom control
- No need for routine growth monitoring in adolescents using standard doses 3